This past week, CTM covered the following issues: In China: * Foreign investment data * Pilot project on foreign-owned hospitals In North America: * Petition for trade remedy investigations on Chinese active anode material * U.S. Congress hearing on Chinese IP practices * Canadian sanctions on Chinese officials At the WTO: * Review of two

A WTO panel has been composed to hear China's complaint against tax credits under the U.S. Inflation Reduction Act (IRA).

Earlier this week, the American Active Anode Material Producers, representing U.S. producers of graphite, filed a petition for the imposition of anti-dumping and countervailing duties on U.S. imports of active anode material (i.e. processed graphite) from China.

Chinese Ministry of Commerce data shows that foreign investment in China has dropped over the first 11 months of this year. However, investment from the Middle East may become a new area for growth.

At a hearing yesterday, members of Congress spoke with several expert witnesses about the problems of dealing with a number of specific Chinese practices related to intellectual property, including SEP-litigation practice.

At today's meeting of the WTO's Dispute Settlement Body, Australia indicated that it had completed implementation of a WTO dispute brought by China related to anti-dumping measures on several products.

Last week, the Canadian government sanctioned eight Chinese officials and former officials. This could trigger another round of retaliatory sanctions, as past experience shows that China has responded to foreign sanctions with its own countermeasures, especially since the enactment of its Anti-Foreign Sanctions Law.